FDA re­vis­es ac­tion on com­pound­ed ibupro­fen, cit­ing oral ver­sion short­age

The FDA put out guid­ance Thurs­day ex­pand­ing sup­ply of a spe­cif­ic form of ibupro­fen, one of the ma­jor ac­tive in­gre­di­ents in over-the-counter pain re­lief med­i­cine such as Advil.

In its newest re­vised guid­ance, the fed­er­al reg­u­la­to­ry agency is now giv­ing the green light to out­sourc­ing fa­cil­i­ties to pro­vide com­pound­ed, oral­ly sus­pend­ed forms of ibupro­fen to state-li­censed phar­ma­cies that can be giv­en to pa­tients at home, pro­vid­ed that a pa­tient has a valid and pa­tient-spe­cif­ic pre­scrip­tion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.